ViroStatics Scientific Advisory Board
ViroStatics' Scientific Advisory Board combines the expertise of internationally recognized experts in the areas of virology, pharmacoloogy, immunology and clinical science.
We sincerely appreciate the advice and counsel given to ViroStatics by these prominent scientists and physicians as they help to guide us on the discovery and clinical development of therapeutic products to combat the global HIV/AIDS pandemic.
| Board Members |
|
|
| |
|
|
| DANIEL R. KURITZKES MD |
|
Professor of Medicine at Harvard Medical School; Director of AIDS Research, Brigham & Women's Hospital in Boston. |
| |
|
|
 |
| |
|
|
| CHARLES FLEXNER MD |
|
Professor of Medicine in the Divisions of Clinical Pharmacology and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine in Baltimore. |
| |
|
|
|
| |
|
|
| ROY M. "Trip" GULICK MD, MPH |
|
Professor of Medicine at Weill Medical College of Cornell University in New York and Director of the Cornell HIV Clinical Trials Unit. |
| |
|
|
|
| |
|
|
| MICHAEL M. LEDERMAN MD |
|
Scott R. Inkley Professor of Medicine, and Professor of Molecular Biology/Microbiology, Pathology and Biomedical Ethics at the Case Western Reserve University (CWRU) ; director of the Center for AIDS Research. |
| |
|
|
|
| |
|
|
| GUIDO SILVESTRI MD |
|
Associate Professor of Pathology & Laboratory Medicine, and Director of Clinical Virology at the Hospital of the University of Pennsylvania. |
| |
|
|
|
| |
|
|
| STEFANO VELLA MD |
|
Manager of the Department of Medicine at the Italian Department of Health and Human Services; member of the Technical Review Panel (TRP) of The Global Fund. |
| |
|
|
|
| |
|
|
| MARK A. WAINBERG PhD |
|
Director of the McGill University AIDS Centre; Professor of Medicine and of Microbiology at McGill University in Montreal, Canada. |
| |
|
|
|
